American Society of Hematology

Figure 2.

$Figure 2. Mortality from disease progression and nonrelapse mortality. Estimates of the cumulative incidences of mortality from disease progression (A) and nonrelapse mortality (B) by disease status at transplantation are shown. CR1/CR2 indicates complete remission 1 (n = 22) or 2 (n = 14); non-CR, patients with refractory disease (n = 27), untreated relapse (n = 7), or untreated primary disease (n = 1).$

Mortality from disease progression and nonrelapse mortality. Estimates of the cumulative incidences of mortality from disease progression (A) and nonrelapse mortality (B) by disease status at transplantation are shown. CR1/CR2 indicates complete remission 1 (n = 22) or 2 (n = 14); non-CR, patients with refractory disease (n = 27), untreated relapse (n = 7), or untreated primary disease (n = 1).

This Feature Is Available To Subscribers Only